Fox Chase Cancer Center Postdoctoral Fellow Wins AACR-Anna D. Barker Fellowship Award
PHILADELPHIA (March 23, 2004) -- The American Association for Cancer Research (AACR) has selected Fox Chase postdoctoral researcher Xiaowei Chen, PhD, of the Fox Chase section of Philadelphia to receive its 2004 AACR-Anna D. Barker Fellowship. The fellowship is given to a postdoctoral fellow or clinical researcher at an academic or research institution to foster basic, translational, clinical and prevention research by scientists at the beginning of their careers in the cancer field.
Chen's fellowship provides a one-year $30,000 grant for direct research expenses. Selection is based on research initiative, creativity, previous accomplishments, the probability of meaningful results from proposed research and the likely contribution of the research to the advancement of the knowledge of cancer.
Chen's postdoctoral research is focused on the identification of new breast and ovarian cancer susceptibility genes. Mutations in genes such as BRCA1 and BRCA2 can increase a woman's lifetime risk of developing breast and ovarian cancer. Chen and his colleagues are evaluating the novel cellular pathways used by BRCA1 and 2 to identify other susceptibility genes.
Chen obtained his B.S. and M.S. in biomedicine from Huazhong University of Science and Technology in Wuhan, China. He earned his Ph.D. in nutritional biochemistry at University of North Carolina at Chapel Hill in 2002. After graduation, Chen joined the Fox Chase laboratory of molecular geneticist Andrew K. Godwin, PhD, where he began his postdoctoral training.
Chen is a member of the American Association for Cancer Research, American Society of Human Genetics and Sigma Xi, the Scientific Research Society.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.